Using the National Cancer Data Base for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer.

Heather Y LinIsabelle BedrosianGildy V BabieraSimona F ShaitelmanHenry M KuererWendy A WoodwardNaoto T UenoYu Shen

Published in: Cancer (2017)

FL factors rather than PL factors appear to contribute disproportionately to the underuse of TT in patients with nonmetastatic IBC. To improve treatment guideline adherence for patients with nonmetastatic IBC, it is critical to identify the specific FL factors associated with TT underuse. More organized FL intervention is required to train physicians and to build multidisciplinary teams. Cancer 2017;123:2618-25. © 2017 American Cancer Society.

Keyphrases

papillary thyroid
randomized controlled trial
primary care
squamous cell
squamous cell carcinoma
adipose tissue
metabolic syndrome
high resolution
machine learning
young adults
childhood cancer
combination therapy
mass spectrometry
artificial intelligence
replacement therapy
insulin resistance
weight loss